Hosted on MSN11mon
What to Do If Your Insulin Is Being Discontinued
Luckily, there are many alternative insulins, both rapid-acting and long-acting. Zilbermint highlights Lantus (insulin glargine) as a good option. Although Levermir and Lantus have different ...
pharmaphorum1mon
Novo hopes hypoglycaemia data will boost Tresiba
Novo Nordisk is applying for an expanded US label for its long-acting insulin Tresiba, hoping to gain an upper hand on Sanofi's older rival Lantus. Its data submitted to the FDA shows that ...
pharmaphorum7d
Rival diabetes combinations Xultophy and Soliqua approved
Both products combine a long acting insulin with a GLP-1 analogue – Xultopy brings together Tresiba and Victoza, while Soliqua (formerly known as LixiLan) combines Lantus with Adlyxin (Lxyumia ...
Medscape17y
Nocturnal Hypoglycemia: Answering the Challenge With Long-acting Insulin Analogs
Review Methods: Relevant trials were found by searching for "(detemir OR glargine) AND nocturnal ... for nocturnal hypoglycemia when receiving long-acting insulin analogs (insulin detemir or ...
Nature5y
Diabetic ketoacidosis, long-acting insulin analogs and pediatric type 1 diabetes mellitus
Use of the long-acting insulin analogs glargine and detemir does not reduce the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus (T1DM), compared with the ...